Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells

Journal of Biological Regulators and Homeostatic Agents

Volumn 18, Issue 1, 2004, Pages 9-17

  Cavaletti, Guido ^a,b   Perseghin, P ^b   Dassi, M ^b   Oggioni, N ^c   Sala, F ^c   Braga, M ^a   Lolli, F ^d   Riccio, P ^e   Carlone, G ^f   Zoia, C ^a   Tagliabue, E ^a   Stanzani, L ^a   Galbiati, S ^a   Rigamonti, L ^a   Marmiroli, P ^a   Ferrarese, C ^a   Frattola, L ^a,g   Tredici, G ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c CTI Europe ^*  (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF BASILICATA   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Experimental allergic encephalomyelitis; Extracorporeal photochemotherapy; Immunomodulation; Multiple sclerosis; Tumor necrosis factor

Indexed keywords

ANTIBODY; LIPOPOLYSACCHARIDE; METHOXSALEN; MYELIN; PSORALEN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL SECRETION; CELL STIMULATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; DRUG MECHANISM; EX VIVO STUDY; FEMALE; IMMUNOMODULATION; LEUKOCYTE ACTIVATION; LEUKOCYTE CULTURE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHOTOCHEMOTHERAPY; RAT; RAT STRAIN; TH1 CELL; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION;

ANIMALIA;

EID: 4444307654     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Hintzen R, Polman CH, Lucas CJ, van Lier RA. Multiple sclerosis: immunological findings and possible implications for therapy. J Neuroimmunol 1992: 39: 1-10.
2. Martin R, Calabresi P, McFarland HF. Experimental immunotherapies of multiple sclerosis. In Zhang J, Hafler D, Hohfeld R, Miller A, eds. London: Martin Dunitz; 1998: 29-73.
3. Martin R, McFarland HF. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 1995: 32: 121-82.
4. Costanzo-Nordin MR, Hubbel EA, O'Sullivan EJ, Robinson JA. Successful treatment of heart transplantation rejection with photopheresis. Transplantation 1992: 53: 808-15.
5. Knobler RM, Graininger W, Lindmaier A, Trautinger F, Smolen J. Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. Arthritis Rheum 1992: 35: 319-24.
6. Edelson RL, Heald PW, Perez MI, Berger C. Extracorporeal photochemotherapy. Biol Ther Cancer Updates 1994: 4: 1-4.
7. Sunder-Plassmann G, Druml W. Steininger R, Honigsmann H, Knobler R. Renal allograft rejection controlled by photopheresis. Lancet 1995: 364: 506.
8. Gerber M, Gmeinhart B, Volc-Platzer B, Kahls P, Greinix H, Knobler R. Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP). Bone Marrow Transplant 1997: 19: 517-9.
9. Barr ML, Meiser BM, Eisen HJ, et al. Photopheresis in the prevention of rejection in cardiac transplantation. N Engl J Med 1998: 339: 1744-51.
10. Greinix HT, Volc-Platzer B, Rabitsch W, et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood 1998: 92: 3098-104.
11. Russel-Jones R. Shedding light on photopheresis. Lancet 2001: 357: 820.
12. Yoo EK, Rook AH, Elenitsas R, Gasparro FP, Vowels BR. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996: 108: 235-42.
13. Aringer M, Graininger WB, Smolen JS, Keiner HP, Steiner LW. Photopheresis treatment enhances CD95 (fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis. Br J Rheumatol 1997: 36: 1276-82.
14. Enomoto DN, Schellekens PT, Yong SL, Ten Berge IJ, Mekkes JR. Extracorporeal photochemotherapy (photopheresis) induces apoptosis in lymphocytes: a possible mechanism of action of PUVA therapy. Phothochem Photobiol 1997: 65: 177-80.
15. Khavari PA, Edelson RL, Lider O, Gasparro FP, Weiner HL, Cohen IR. Specific vaccination against photoinactivated cloned T cells. Clin Res 1998: 36: 662A.
16. Poehlau D, Rieks M, Postert T et al. Photopheresis - A possible treatment of multiple sclerosis?: Report of two cases. J Clin Apher 1997: 12: 154-5.
17. Rostami AM, Sater RA, Bird SJ, et al. A double-blind, placebo-controlled trial of extracorporeal photopheresis in chronic progressive multiple sclerosis. Mult Scler 1999: 5: 198-203.
18. Besnier DP, Chabannes D, Mussini J-MG, Dupas B, Esnault VLM. Extracorporeal photochemotherapy for secondary chronic progressive multiple sclerosis: A pilot study. Photodermatol Photoimmunol Photomed 2002: 18: 36-41.
19. Cavaletti G, Perseghin P, Buscemi F, et al. Immunomodulating effects of extracorporeal Photochemotherapy (ECP) in rat experimental allergic encephalomyelitis (EAE). Int J Tissue React 2001: 23: 21-31.
20. Wekerle H, Kojima K, Lannes Vieira J, Lassmann H, Linington C. Animal models. Ann Neurol 1994: 36 (Suppl.): S47.
21. Andreu G, Leon A, Heshmati F, Tod M, Menkes CJ, Baudelot J, Laroche L. Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders. Tranfus Sci 1994: 15: 443-54.
22. Perotti C, Torretta L, Viarengo G, et al. Feasibility and safety of a new technique of ECP: Experience of 240 procedures. Hematologica 1999: 84: 237-41.
23. Birnbaum G, Kotilinek L, Miller S, Raine CS, Gao YL. Heat shock proteins and experimental autoimmune encephalomyelitis II: Environmental infections and extra-neuraxial inflammation alter the course of chronic relapsing encephalomyelitis. J Neuroimmunol 1998: 90: 149-61.
24. Lolli F, Liuzzi GM, Vergelli M, et al. Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis. J Neuroimmunol 1993: 44: 69-75.
25. Cavaletti G, Perseghin P, Dassi M, et al. Extracorporeal photochemotherapy reduces the incidence of relapses in experimental allergic encephalomyelitis in DA rats. J Neurol 2001: 248: 535-6.
26. Levine S, Saltzman A. Nonspecific stress prevents relapses of experimental allergic encephalomyelitis in rats. Brain Behav Immun 1987: 1: 336-41.
27. Villas PA, Dronsfield MJ, Blankenhorn E. Experimental allergic encephalomyelitis and corticosterone studies in resistant and susceptible rat strains. Clin Immunol Immunopathol 1991: 61: 29-40.
28. Griffin AC, Lo WD, Wolny AC, Withacre CC. Suppression of experimental autoimmune encephalomyelitis by restraint stress: Sex differences. J Neuroimmunol 1993: 44: 103-16.
29. Kuroda Y, Mori T, Hori T. Restraint stress suppresses experimental allergic encephalomyelitis in Lewis rats. Brain Res Bull 1994: 34: 15-7.
30. Laban O, Dimitrijevic M, von Hoersten S, Markovic BM, Jankovic BD. Experimental allergic encephalomyelitis in aduk DA rats subjected to neonatal handling or gentling. Brain Res 1995: 676: 133-40.
31. Laban O, Markovic BM, Dimitrijevic M, Jankovic BD. Maternal deprivation and early weaning modulate experimental allergic encephalomyelitis in the rat. Brain Behav Immun 1995; 9: 9-19.
32. Poliak S, Mor F, Conlon P, et al. Stress and autoimmunity. J Neuroimmunol 1997; 158: 5751-6.
33. Vukmanovic S, Mostarica-Stojkovic M, Zalud I, Ramic Z, Lukic ML. Analysis of cell subsets after induction of experimental autoimmune encephalomyelitis in susceptible and resistant strains of rats. J Neuroimmunol 1990: 27: 63-9.
34. Traugot U. Expenmental allergic encephalomyelitis - Migration of early T cells from the circulation into the central nervous system. J Neurol Sci 1978: 36: 55-63.
35. Hauser SL, Bahn AK, Che M, Gilles F, Weiner HL. Redistribution of Lyt- bearing T cells in acute murine experimental allergic encephalomyelitis. Selective migration of Lyt-1 cells to the central nervous system is associated with a transient depletion of Lyt-1 cells in peripheral blood. J Neuroimmunol 1984: 133: 3037-42.
36. Van Lambalgen R, Jonker M. Experimental allergic encephlomyelitis in rhesus monkies. I. Immunological parameters in EAE resistant and susceptible rhesus monkies. Clin Exp Immunol 1987: 68: 100-7.
37. Kaser A, Deisenhammer F, Berger T, Tilg H. Interferon-β1b augments activation-induced T-cell death in multiple sclerosis patients. Lancet 1999: 353: 1413-4.
38. Yasumoto S, Moroi Y, Koga T, Kawamura I, Mitsuyama M, Hori Y. Ultraviolet-B irradiation alters cytokine production by immune lymphocytes in herpes simplex virus-infected mice. J Dermatol Sci 1994: 8: 218-23.
39. Schmitt DA, Owen-Schaub L, Ullrich SE. Effect of IL-12 on immune suppression and suppressor cell induction by ultraviolet radiation. J Immunol 1995: 154: 5114-20.
40. Aragane Y, Schwarz A, Luger TA, Ariizumi K, Talkashima A, Schwarz T. Ultraviolet light suppresses IFN-gamma-induced IL-7 gene expression in murine keratinocytes by interfering with IFN regulatory factors. J Immunol 1997: 158: 5393-9.
41. El-Ghorr AA, Norval M. The role of interleukin-4 in ultraviolet B light-induced immunosuppression. Immunol 1997: 92: 26-32.
42. El-Ghorr AA, Horsburg G, Norval M. The effect of UVB irradiation on antibody responses during herpes simplex virus type 1 (HSV-1) infection of mice. Photodermatol Photoimmunol Photomed 1998: 14: 17-25.
43. Stanzani L, Zoia C, Tagliabue E, et al. Extracorporeal photochemotherapy induces similar modifications of cytokine release in the Lewis rat EAE model and in human multiple sclerosis. Neurol Sci 2001; 22 (Suppl.): S28.
44. Danno K, Kaji A, Mochizuki T. Alterations in ICAM-1 and ELAM-1 expression in psoriatic lesions following various treatments. J Dermatol Sci 1996: 13: 49-55.
45. Perez M, Edelson R, Laroche L, Berger C. Inhibition of antiskin allograft immunity by infusion with syngenic photoactivated effector lymphocytes. J Invest Dernatol 1996: 92: 669-76.
46. Fritz TM, Kleinhans M, Nestle FO, Burg G, Dummer R. Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with Sezary syndrome. Br J Dermatol 1999; 140: 1144-7.
47. Chabannes D, Besnier DP, Esnault VLM. Photopheresis affects the course of experimental allergic encephalomyelitis in Lewis rats. Photodermatol Photoimmunol Photomed 2002: 18: 238-43.